ncDR

MiRNA	Compound	Condition	Effect	Throughput	PMID	Details
miR-205	Erlotinib	epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC))	Sensitive	High	22045191	More
miR-205	Erlotinib	melanoma	Sensitive	Low	23447575	More